Abstract
Ehlers-Danlos syndrome (EDS) is an emerging cause of skeletal fragility. Mechanism of bone damage are probably multifactorial in line with the different skeletal phenotypes that can be found in clinical practice. A structured approach to clinical management of bone metabolic complication in EDS is proposed.
Original language | English |
---|---|
Pages (from-to) | 225-230 |
Number of pages | 6 |
Journal | Endocrine |
Volume | 63 |
Issue number | 2 |
Early online date | Dec 15 2018 |
DOIs | |
Publication status | Published - 2019 |